Daniel Gustavo Miquelin

Percutaneous transluminal angioplasty in the treatment of stenosis of arteriovenous fistulae for hemodialysis

Background Thrombosis following stenosis of arteriovenous fistulae resulting in the loss of vascular access for hemodialysis is an important complication in patients with chronic renal failure. Percutaneous transluminal angioplasty is being used more frequently in the treatment of stenosis aiming at increasing the patency of arteriovenous fistulae. Objective To evaluate the primary patency of arteriovenous fistulae following percutaneous transluminal angioplasty. Patients and method Patients submitted to percutaneous transluminal angioplasty in the Angiology service of Hospital de Base in 2004 were analyzed over an average follow-up of 10 months (2 to 16 months). Results A total of 22 angioplasties were performed in 20 fistulae of 19 patients. Of the 19 patients, one did not complete follow-up and one presented with a rupture of the fistulae. The following complications occurred in the remaining 18 fistulae, three deaths with two fistulae patent until death; one exeresis of prosthesis due to infection (53 days after the procedure); two thromboses (3 and 49 days after the procedure) and four restenosis (3 were submitted to a second angioplasty and one treated surgically). At the end of the follow-up, 11 fistulae (55%) were patent and with a flow rate in hemodialysis > 300 mL/min. Primary patency was 82.4% over three months; 81.2% over six months; 54.5% over 9 months and 50% over 1 year. Conclusion Percutaneous transluminal angioplasty is an efficacious method for the correction of stenosis of arteriovenous fistulae for hemodialysis, prolonging the patency of the fistula and enabling new interventions.

Tratamento endovascular de aneurisma de ilíaca roto: relato de caso

The surgical mortality rate of ruptured iliac aneurysms is similar to ruptured abdominal aortic aneurysms in terms of their location deep in the pelvis, difficult access to the distal iliac artery due to hematoma, adherences due to prior laparotomy and proximity of the ureter and venous structures. This study aims at highlighting the endovascular procedure as an alternative in the correction of this lesion. We report the case of a patient submitted to aortobiiliac prosthetic graft due to infrarenal abdominal aortic aneurysm 5 years ago, who presented with a ruptured aneurysm in the remaining segment of the left common iliac artery. The patient was hemodynamically stable after fluid replacement therapy and was submitted to urgent endovascular treatment. The treatment resulted in the exclusion of the aneurysm without endoleaks.

Braile vena cava filter and greenfield filter in terms of centralization.

The aim of this study was to evaluate complications experienced during implantation of the Braile Vena Cava filter (VCF) and the efficacy of the centralization mechanism of the filter. This retrospective cohort study evaluated all Braile Biomédica VCFs implanted from 2004 to 2009 in Hospital de Base Medicine School in São José do Rio Preto, Brazil. Of particular concern was the filter’s symmetry during implantation and complications experienced during the procedure. All the angiographic examinations performed during the implantation of the filters were analyzed in respect to the following parameters: migration of the filter, non-opening or difficulties in the implantation and centralization of the filter. A total of 112 Braile CVFs were implanted and there were no reports of filter opening difficulties or in respect to migration. Asymmetry was observed in 1/112 (0.9%) cases. A statistically significant difference was seen on comparing historical data on decentralization of the Greenfield filter with the data of this study. The Braile Biomédico filter is an evolution of the Greenfield filter providing improved embolus capture and better implantation symmetry.